$BLMH.C (Bloom Health Partners) is pushing up 17% today due to their extremely impressive fiscal Q2 2022 results. I'll list some of the highlights from the release below.
- Revenues reached $11.1M, which shows 92.1% growth over the previous quarter. (Brings the total fiscal YTD numbers to $16.9M).
- EBITDA hit $2.1M over $(497)K last year, and they reported a net income before tax of $875K.
- Strong cash position with over $1.7M on hand and $8.7M in receivables.
- A lot of this growth can be attributed to the many partnerships and deals they've secured over the past couple of months, including a contract announced with State of Texas K-12 schools.
- Bloom Shield health-tech software platform for workplace health deployments. Their proprietary software helps organizations utilize Bloom health services for workplace productivity.
Read the full release here: https://ca.finance.yahoo.com/news/bloom-health-partners-reports-profitable-123000181.html
Considering that their revenue targets were $25M-$28M for the 2022 fiscal year, and they’ve already hit $16.9M halfway through (and are continuing to grow quarter after quarter), there's a lot of upside at these levels. $9M market cap with $11.1M revenue and positive EBITDA from a single quarter, it's a no-brainer to say this is undervalued.
(CSE: BLMH) (OTC: BLMHF)